FOLD
Amicus Therapeutics, Inc.$14.49+0.04 (+0.28%)Prev Close$14.46·MCap$4.55B·P/E—·Vol3.11M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
10
$5.09M
◆
Net Activity
Net Seller
$5.09M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Amicus Therapeutics, Inc. (FOLD) has been exclusively selling, with 0 insider purchases totaling $0.00 and 10 insider sales totaling $5.09M. The most recent insider transaction was by Campbell Bradley L (director, officer: President and CEO), who sold $1.07M worth of shares on Jan 22, 2026. Amicus Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $4.55B.
FOLD Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Campbell Bradley L | director, officer: President and CEO | Sell | 75,000 | $14.31 | $1.07M | 1,021,180 |
| Dec 23, 2025 | Clark David Michael | Chief People Officer | Sell | 25,642 | $14.17 | $363.4K | 245,690 |
| Dec 17, 2025 | Campbell Bradley L | President and CEO | Sell | 77,926 | $10.86 | $846.0K | 1,129,782 |
| Dec 17, 2025 | Clark David Michael | Chief People Officer | Sell | 25,643 | $11.00 | $282.1K | 271,332 |
| Dec 3, 2025 | Campbell Bradley L | President and CEO | Sell | 14,587 | $10.01 | $146.0K | 1,137,282 |
| Nov 26, 2025 | Campbell Bradley L | President and CEO | Sell | 14,587 | $10.04 | $146.5K | 1,137,282 |
| Nov 26, 2025 | Castelli Jeff | Chief Development Officer | Sell | 76,158 | $10.16 | $773.7K | 439,318 |
| Nov 26, 2025 | Clark David Michael | Chief People Officer | Sell | 25,643 | $10.10 | $258.9K | 296,975 |
| Nov 26, 2025 | Rosenberg Ellen | Chief Legal Officer | Sell | 95,621 | $10.02 | $958.5K | 507,710 |
| Nov 5, 2025 | Clark David Michael | Chief People Officer | Sell | 25,643 | $9.51 | $243.9K | 322,618 |
| Feb 21, 2025 | Campbell Bradley L | President and CEO | Sell | 400 | $10.00 | $4.0K | 1,150,657 |
| Dec 3, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.02 | $75.1K | 886,654 |
| Nov 7, 2024 | Campbell Bradley L | President and CEO | Sell | 7,901 | $12.50 | $98.8K | 886,654 |
| Nov 4, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $11.46 | $86.0K | 886,654 |
| Oct 4, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.60 | $79.5K | 886,654 |
| Sep 5, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $11.71 | $87.8K | 886,654 |
| Aug 5, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.34 | $77.5K | 886,654 |
| Jul 9, 2024 | Campbell Bradley L | President and CEO | Sell | 6,100 | $10.00 | $61.0K | 886,654 |
| Jul 3, 2024 | Campbell Bradley L | President and CEO | Sell | 1,400 | $10.00 | $14.0K | 886,654 |
| Jun 5, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.00 | $75.0K | 886,654 |
| May 3, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.07 | $75.5K | 886,654 |
| Apr 3, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $11.67 | $87.5K | 886,654 |
| Mar 6, 2024 | MCGLYNN MARGARET G | Sell | 15,000 | $13.35 | $200.2K | 59,289 | |
| Mar 5, 2024 | Campbell Bradley L | President and CEO | Sell | 15,833 | $13.14 | $208.0K | 871,219 |
| Mar 5, 2024 | Crowley John F | Executive Chairman | Sell | 29,181 | $13.35 | $389.5K | 573,478 |
| Feb 20, 2024 | Campbell Bradley L | President and CEO | Sell | 4,167 | $14.00 | $58.3K | 871,219 |
| Feb 20, 2024 | Clark David Michael | Chief People Officer | Sell | 4,427 | $14.00 | $62.0K | 253,664 |
| Feb 20, 2024 | Crowley John F | Executive Chairman | Sell | 31,614 | $13.81 | $436.6K | 697,628 |
| Feb 8, 2024 | Rosenberg Ellen | Chief Legal Officer | Sell | 30,000 | $13.00 | $390.0K | 367,654 |
| Feb 5, 2024 | Campbell Bradley L | President and CEO | Sell | 15,833 | $12.56 | $198.9K | 875,386 |
| Feb 5, 2024 | Crowley John F | Executive Chairman | Sell | 31,614 | $12.62 | $398.9K | 750,838 |
| Jan 24, 2024 | Crowley John F | Executive Chairman | Sell | 55,327 | $12.36 | $684.0K | 782,452 |
| Jan 18, 2024 | Crowley John F | Executive Chairman | Sell | 31,614 | $12.78 | $404.1K | 837,779 |
| Jan 11, 2024 | Crowley John F | Executive Chairman | Sell | 31,614 | $13.65 | $431.5K | 869,393 |
| Jan 9, 2024 | Clark David Michael | Chief People Officer | Sell | 10,110 | $14.00 | $141.5K | 268,089 |
| Jan 9, 2024 | Prout Samantha | Chief Accounting Officer | Sell | 32,104 | $14.00 | $449.5K | 82,290-28% |
| Jan 4, 2024 | Campbell Bradley L | President and CEO | Sell | 15,833 | $14.23 | $225.4K | 947,805 |
| Jan 4, 2024 | Rosenberg Ellen | Chief Legal Officer | Sell | 30,000 | $14.21 | $426.2K | 342,285 |
| Dec 29, 2023 | Castelli Jeff | Chief Development Officer | Sell | 17,421 | $14.52 | $252.9K | 340,661 |
| Dec 28, 2023 | Prout Samantha | Chief Accounting Officer | Sell | 7,659 | $14.00 | $107.2K | 121,912 |
| Dec 28, 2023 | Rosenberg Ellen | Chief Legal Officer | Sell | 35,000 | $14.01 | $490.4K | 342,285 |
| Dec 20, 2023 | Castelli Jeff | Chief Development Officer | Sell | 19,154 | $13.24 | $253.5K | 359,736 |
| Dec 19, 2023 | Crowley John F | Executive Chairman | Sell | 6,043 | $12.66 | $76.5K | 877,748 |
| Dec 5, 2023 | Campbell Bradley L | President and CEO | Sell | 11,702 | $11.08 | $129.7K | 792,161 |
| Dec 5, 2023 | Crowley John F | Executive Chairman | Sell | 6,043 | $11.08 | $67.0K | 883,791 |
| Nov 17, 2023 | Crowley John F | Executive Chairman | Sell | 6,043 | $10.84 | $65.5K | 889,834 |
| Nov 3, 2023 | Campbell Bradley L | President and CEO | Sell | 11,700 | $10.97 | $128.4K | 792,161 |
| Nov 3, 2023 | Crowley John F | Executive Chairman | Sell | 6,044 | $10.97 | $66.3K | 895,877 |
| Oct 18, 2023 | Crowley John F | Executive Chairman | Sell | 6,044 | $10.50 | $63.4K | 901,921 |
| Oct 4, 2023 | Campbell Bradley L | President & CEO | Sell | 11,700 | $11.24 | $131.5K | 792,661 |
Showing 1–50 of 165
1 / 4
FOLD Insider Buying Activity
The following table shows recent insider purchases of Amicus Therapeutics, Inc. (FOLD) stock reported via SEC Form 4 filings.
No insider buying activity found for FOLD in the last 12 months.
FOLD Insider Selling Activity
The following table shows recent insider sales of Amicus Therapeutics, Inc. (FOLD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Campbell Bradley L | director, officer: President and CEO | Sell | 75,000 | $14.31 | $1.07M | 1,021,180 |
| Dec 23, 2025 | Clark David Michael | Chief People Officer | Sell | 25,642 | $14.17 | $363.4K | 245,690 |
| Dec 17, 2025 | Campbell Bradley L | President and CEO | Sell | 77,926 | $10.86 | $846.0K | 1,129,782 |
| Dec 17, 2025 | Clark David Michael | Chief People Officer | Sell | 25,643 | $11.00 | $282.1K | 271,332 |
| Dec 3, 2025 | Campbell Bradley L | President and CEO | Sell | 14,587 | $10.01 | $146.0K | 1,137,282 |
| Nov 26, 2025 | Campbell Bradley L | President and CEO | Sell | 14,587 | $10.04 | $146.5K | 1,137,282 |
| Nov 26, 2025 | Castelli Jeff | Chief Development Officer | Sell | 76,158 | $10.16 | $773.7K | 439,318 |
| Nov 26, 2025 | Clark David Michael | Chief People Officer | Sell | 25,643 | $10.10 | $258.9K | 296,975 |
| Nov 26, 2025 | Rosenberg Ellen | Chief Legal Officer | Sell | 95,621 | $10.02 | $958.5K | 507,710 |
| Nov 5, 2025 | Clark David Michael | Chief People Officer | Sell | 25,643 | $9.51 | $243.9K | 322,618 |
| Feb 21, 2025 | Campbell Bradley L | President and CEO | Sell | 400 | $10.00 | $4.0K | 1,150,657 |
| Dec 3, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.02 | $75.1K | 886,654 |
| Nov 7, 2024 | Campbell Bradley L | President and CEO | Sell | 7,901 | $12.50 | $98.8K | 886,654 |
| Nov 4, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $11.46 | $86.0K | 886,654 |
| Oct 4, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.60 | $79.5K | 886,654 |
| Sep 5, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $11.71 | $87.8K | 886,654 |
| Aug 5, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.34 | $77.5K | 886,654 |
| Jul 9, 2024 | Campbell Bradley L | President and CEO | Sell | 6,100 | $10.00 | $61.0K | 886,654 |
| Jul 3, 2024 | Campbell Bradley L | President and CEO | Sell | 1,400 | $10.00 | $14.0K | 886,654 |
| Jun 5, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.00 | $75.0K | 886,654 |
| May 3, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $10.07 | $75.5K | 886,654 |
| Apr 3, 2024 | Campbell Bradley L | President and CEO | Sell | 7,500 | $11.67 | $87.5K | 886,654 |
| Mar 6, 2024 | MCGLYNN MARGARET G | Sell | 15,000 | $13.35 | $200.2K | 59,289 | |
| Mar 5, 2024 | Campbell Bradley L | President and CEO | Sell | 15,833 | $13.14 | $208.0K | 871,219 |
| Mar 5, 2024 | Crowley John F | Executive Chairman | Sell | 29,181 | $13.35 | $389.5K | 573,478 |
| Feb 20, 2024 | Campbell Bradley L | President and CEO | Sell | 4,167 | $14.00 | $58.3K | 871,219 |
| Feb 20, 2024 | Clark David Michael | Chief People Officer | Sell | 4,427 | $14.00 | $62.0K | 253,664 |
| Feb 20, 2024 | Crowley John F | Executive Chairman | Sell | 31,614 | $13.81 | $436.6K | 697,628 |
| Feb 8, 2024 | Rosenberg Ellen | Chief Legal Officer | Sell | 30,000 | $13.00 | $390.0K | 367,654 |
| Feb 5, 2024 | Campbell Bradley L | President and CEO | Sell | 15,833 | $12.56 | $198.9K | 875,386 |
| Feb 5, 2024 | Crowley John F | Executive Chairman | Sell | 31,614 | $12.62 | $398.9K | 750,838 |
| Jan 24, 2024 | Crowley John F | Executive Chairman | Sell | 55,327 | $12.36 | $684.0K | 782,452 |
| Jan 18, 2024 | Crowley John F | Executive Chairman | Sell | 31,614 | $12.78 | $404.1K | 837,779 |
| Jan 11, 2024 | Crowley John F | Executive Chairman | Sell | 31,614 | $13.65 | $431.5K | 869,393 |
| Jan 9, 2024 | Clark David Michael | Chief People Officer | Sell | 10,110 | $14.00 | $141.5K | 268,089 |
| Jan 9, 2024 | Prout Samantha | Chief Accounting Officer | Sell | 32,104 | $14.00 | $449.5K | 82,290-28% |
| Jan 4, 2024 | Campbell Bradley L | President and CEO | Sell | 15,833 | $14.23 | $225.4K | 947,805 |
| Jan 4, 2024 | Rosenberg Ellen | Chief Legal Officer | Sell | 30,000 | $14.21 | $426.2K | 342,285 |
| Dec 29, 2023 | Castelli Jeff | Chief Development Officer | Sell | 17,421 | $14.52 | $252.9K | 340,661 |
| Dec 28, 2023 | Prout Samantha | Chief Accounting Officer | Sell | 7,659 | $14.00 | $107.2K | 121,912 |
| Dec 28, 2023 | Rosenberg Ellen | Chief Legal Officer | Sell | 35,000 | $14.01 | $490.4K | 342,285 |
| Dec 20, 2023 | Castelli Jeff | Chief Development Officer | Sell | 19,154 | $13.24 | $253.5K | 359,736 |
| Dec 19, 2023 | Crowley John F | Executive Chairman | Sell | 6,043 | $12.66 | $76.5K | 877,748 |
| Dec 5, 2023 | Campbell Bradley L | President and CEO | Sell | 11,702 | $11.08 | $129.7K | 792,161 |
| Dec 5, 2023 | Crowley John F | Executive Chairman | Sell | 6,043 | $11.08 | $67.0K | 883,791 |
| Nov 17, 2023 | Crowley John F | Executive Chairman | Sell | 6,043 | $10.84 | $65.5K | 889,834 |
| Nov 3, 2023 | Campbell Bradley L | President and CEO | Sell | 11,700 | $10.97 | $128.4K | 792,161 |
| Nov 3, 2023 | Crowley John F | Executive Chairman | Sell | 6,044 | $10.97 | $66.3K | 895,877 |
| Oct 18, 2023 | Crowley John F | Executive Chairman | Sell | 6,044 | $10.50 | $63.4K | 901,921 |
| Oct 4, 2023 | Campbell Bradley L | President & CEO | Sell | 11,700 | $11.24 | $131.5K | 792,661 |
FOLD Insiders
Similar Stocks to FOLD
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B